DIMAZON 50 MG/ML SOLUTION FOR INJECTION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
15-07-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FUROSEMIDE
Available from:
Intervet Ireland Limited
ATC code:
QC03CA01
INN (International Name):
FUROSEMIDE
Dosage:
50 Mg/Ml
Pharmaceutical form:
Solution for Injection
Prescription type:
POM
Therapeutic group:
Bovine, Canine, Equine - Food, Feline
Therapeutic area:
Furosemide
Therapeutic indications:
Cardiovascular
Authorization status:
Authorised
Authorization date:
1995-10-01
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dimazon 50 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A slightly yellowing fluid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horses, dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Supportive therapy in all cases in which non inflammatory accumulation of fluid of various origins should be
reabsorbed from tissue body cavities, joints, tendon sheaths etc. by means of increased diuresis/saluresis e.g. oedema
associated with cardiac insufficiency, renal dysfunction, trauma and parasitic disease. It is also recommended for the
treatment of mammary oedema and limb oedema.
4.3 CONTRAINDICATIONS
Do not use in cases of liver coma, renal deficiency with anuria, electrolyte deficiency (hypokalemia, hyponatremia),
hypotony and sulfonamide allergy.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Clinical experience with dogs indicates that improved results can be frequently achieved by supplementary
administration of corticosteroids.
Each ml contains:
ACTIVE SUBSTANCE
Furosemide
50 mg
(as monoethanolamine salt)
EXCIPIENTS:
Benzyl alcohol
15.0 mg
Sodium sulphite, anhydrous
1.8 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 30/06/2016_
_CRN 7023977_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
When cardiac glycosides are used, furosemide should be applied only for the first 3 days.
In dogs after a simultaneous use of furosemide and digoxin preparations an undesired increased digoxin-effect may
occur. Therefore it is recommended to reduce the digox
Read the complete document
